Literature DB >> 29415155

Prognostic value of Twist, Snail and E-cadherin expression in pathological N0 non-small-cell lung cancer: a retrospective cohort study.

Guanghui Wang1, Wei Ma1, Yun Li1, Yuanzhu Jiang1, Guoyuan Ma1, Xiangwei Zhang1, Long Meng1, Jiajun Du1,2.   

Abstract

OBJECTIVES: Lung cancer is the leading cause of cancer-related death worldwide. The 5-year survival rate for patients after curative surgery with pathological N0 non-small-cell lung cancer (NSCLC) is as low as 56%, which is due to recurrence and metastasis. Emerging evidence suggests that epithelial-mesenchymal transition is important for cancer metastasis. Twist and Snail are epithelial-mesenchymal transition regulators that induce metastasis by down-regulating E-cadherin. The aim of this study was to evaluate the prognostic value of Twist, Snail and E-cadherin expression in patients with resectable pathological N0 NSCLC.
METHODS: The expression levels of Twist, Snail and E-cadherin in 78 patients with resected pathological N0 NSCLC were assessed using immunohistochemistry. The association between the expression of Twist/Snail/E-cadherin and overall survival (OS) and recurrence-free survival (RFS) was investigated.
RESULTS: High expression of Twist, Snail and E-cadherin was detected in 18%, 21% and 53% of NSCLC samples, respectively. High expression of Twist and Snail and low expression of E-cadherin were associated with worse RFS [hazard ratio (HR) 2.29, 95% confidence interval (CI) 1.07-4.87, P = 0.026; HR 2.54, 95% CI 1.24-5.20, P = 0.008 and HR 2.41, 95% CI 1.23-4.73, P = 0.007, respectively] and worse OS (HR 2.26, 95% CI 1.01-5.04, P = 0.040; HR 2.56, 95% CI 1.20-5.43, P = 0.011 and HR 2.42, 95% CI 1.18-4.95, P = 0.012, respectively). Co-expression of at least 2 markers from the combination of high Twist/high Snail/low E-cadherin expression predicted poor RFS and OS (HR 4.12, 95% CI 2.08-8.16, P < 0.001 and HR 4.28, 95% CI 2.08-8.77, P < 0.001, respectively), and it was an independent predictor of RFS and OS (HR 3.99, 95% CI 1.89-8.44, P < 0.001 and HR 4.16, 95% CI 1.88-9.18, P < 0.001, respectively).
CONCLUSIONS: Co-expression of at least 2 markers from the combination of high Twist/high Snail/low E-cadherin expression was a significant prognostic predictor in patients with pathological N0 NSCLC.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29415155     DOI: 10.1093/ejcts/ezy022

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  10 in total

1.  Visiting an old foe: distant recurrence following R0 lobectomy for pathological N0 lung adenocarcinoma.

Authors:  Sameer A Hirji; Thomas A D'Amico
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

2.  E-Cadherin and Syndecan-1 Expression in Patients With Advanced Non-small Cell Lung Cancer Treated With Chemoradiotherapy.

Authors:  Pinelopi Gkogkou; Evangelia Peponi; Dimitrios Ntaskagiannis; Samuel Murray; Asimo Demou; Ioannis Sainis; Elli Ioakeim; Evangelos Briasoulis; Pericles Tsekeris
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

3.  IKKα Promotes the Progression and Metastasis of Non-Small Cell Lung Cancer Independently of its Subcellular Localization.

Authors:  Angustias Page; Alba Ortega; Josefa P Alameda; Manuel Navarro; Jesús M Paramio; Melchor Saiz-Pardo; Edilia I Almeida; Pilar Hernández; M Jesús Fernández-Aceñero; Rosa A García-Fernández; M Llanos Casanova
Journal:  Comput Struct Biotechnol J       Date:  2019-02-07       Impact factor: 7.271

4.  Mannose Suppresses the Proliferation and Metastasis of Lung Cancer by Targeting the ERK/GSK-3β/β-Catenin/SNAIL Axis.

Authors:  Qingsong Luo; Bei Li; Gang Li
Journal:  Onco Targets Ther       Date:  2020-04-02       Impact factor: 4.147

5.  Clinicopathological significance and prognostic value of E-cadherin expression in non-small cell lung cancer: A protocol for systematic review and meta-analysis.

Authors:  Dong Chao; Gawei Hu; Qingxin Li
Journal:  Medicine (Baltimore)       Date:  2021-02-19       Impact factor: 1.817

6.  Radiation exposure triggers the malignancy of non‑small cell lung cancer cells through the activation of visfatin/Snail signaling.

Authors:  Liang Xiao; Yiwen Mao; Zhuting Tong; Ye Zhao; Hao Hong; Fan Wang
Journal:  Oncol Rep       Date:  2021-01-08       Impact factor: 3.906

7.  TIPE3 promotes non-small cell lung cancer progression via the protein kinase B/extracellular signal-regulated kinase 1/2-glycogen synthase kinase 3β-β-catenin/Snail axis.

Authors:  Qiang Li; Dongmei Yu; Zhengyuan Yu; Qian Gao; Ruifang Chen; Lin Zhou; Rong Wang; Yan Li; Yulan Qian; Jun Zhao; Rafael Rosell; Min Tao; Yufeng Xie; Chun Xu
Journal:  Transl Lung Cancer Res       Date:  2021-02

8.  Targeting the EMT transcription factor Snail overcomes resistance to osimertinib in EGFR-mutant non-small cell lung cancer.

Authors:  Qiong Qin; Xiaoqing Li; Xingmei Liang; Lili Zeng; Jing Wang; Linlin Sun; Diansheng Zhong
Journal:  Thorac Cancer       Date:  2021-05-04       Impact factor: 3.500

Review 9.  SNAIL1: Linking Tumor Metastasis to Immune Evasion.

Authors:  Xiaolong Tang; Xue Sui; Liang Weng; Yongshuo Liu
Journal:  Front Immunol       Date:  2021-11-30       Impact factor: 7.561

Review 10.  Lamins in Lung Cancer: Biomarkers and Key Factors for Disease Progression through miR-9 Regulation?

Authors:  Julien Guinde; Diane Frankel; Sophie Perrin; Valérie Delecourt; Nicolas Lévy; Fabrice Barlesi; Philippe Astoul; Patrice Roll; Elise Kaspi
Journal:  Cells       Date:  2018-07-16       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.